Literature DB >> 17069967

Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG.

Hugh Mitchell1, Michael J Seckl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17069967     DOI： 10.1016/j.mce.2006.09.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN： 0303-7207            Impact factor:   4.102


× No keyword cloud information.
  3 in total

1.  Antibody recognition of a human chorionic gonadotropin epitope (hCGbeta66-80) depends on local structure retained in the free peptide.

Authors:  Craig R Gregor; Eleonora Cerasoli; James Schouten; Jascindra Ravi; Jerry Slootstra; Adrian Horgan; Glenn J Martyna; Maxim G Ryadnov; Paul Davis; Jason Crain
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

Review 2.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

Review 3.  A review on management of gestational trophoblastic neoplasia.

Authors:  Seyedeh Reyhaneh Yousefi Sharami; Elham Saffarieh
Journal:  J Family Med Prim Care       Date:  2020-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.